A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

More young people are being diagnosed with type 2 diabetes and the country is potentially facing a "major health crisis", ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The instant success of weight loss drugs in India tells us how quickly the country is changing. And for once, the change is ...

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid weight loss. Ozempic is for type 2 diabetes. Mounjaro targets two hormone ...

Dr Reddy’s shares drop over 5% following a regulatory setback for its weight-loss drug in Canada, risking future revenues.

America’s obesity rate is on the decline, a new Gallup poll published Tuesday shows, falling nearly three percent as the use ...